Royal Bank of Canada
MIST icon

Royal Bank of Canada’s Milestone Pharmaceuticals MIST Stock Holding History

Royal Bank of Canada’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Hold
6,698
– – ﹤0.01% 6727
2026
Q1 		$8K Hold
6,698
– – ﹤0.01% 6258
2025
Q4 		$13K Sell
6,698
-136,702
-95% -$294K ﹤0.01% 6290
2025
Q3 		$287K Buy
143,400
+107,800
+303% +$190K ﹤0.01% 4860
2025
Q2 		$69K Buy
35,600
+25,600
+256% +$34.1K ﹤0.01% 5779
2025
Q1 		$8K Buy
+10,000
New +$19.9K ﹤0.01% 6228
2024
Q4 		– Sell
-800
Closed -$1K – 7101
2024
Q3 		$1K Buy
+800
New +$1.16K ﹤0.01% 6724
2023
Q1 		– Sell
-2,000
Closed -$8K – 7318
2022
Q4 		$8K Hold
2,000
– – ﹤0.01% 6614
2022
Q3 		$18K Sell
2,000
-16,500
-89% -$125K ﹤0.01% 6188
2022
Q2 		$114K Sell
18,500
-8,002
-30% -$49.2K ﹤0.01% 5238
2022
Q1 		$170K Buy
26,502
+499
+2% +$3.12K ﹤0.01% 5228
2021
Q4 		$170K Sell
26,003
-192
-0.7% -$1.15K ﹤0.01% 5489
2021
Q3 		$149K Buy
26,195
+25,996
+13,063% +$147K ﹤0.01% 5418
2021
Q2 		$1K Sell
199
-104
-34% -$590 ﹤0.01% 7326
2021
Q1 		$2K Buy
303
+147
+94% +$1.08K ﹤0.01% 7244
2020
Q4 		$1K Buy
+156
New +$1.04K ﹤0.01% 6954

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Royal Bank of Canada's MIST Position: Q2 2026 in Review

Royal Bank of Canada held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 6,698 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #6727.

Royal Bank of Canada first reported a position in MIST in Q4 2020 and has held it in 16 quarters since. The position peaked at $287K in Q3 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Royal Bank of Canada held 6,698 shares of Milestone Pharmaceuticals worth $9K as of Q2 2026.
  • Royal Bank of Canada left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6727 holding.
  • Royal Bank of Canada first reported a position in Milestone Pharmaceuticals in Q4 2020 and has held it in 16 quarters since.
  • Royal Bank of Canada's Milestone Pharmaceuticals position peaked at $287K in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.